These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Muscular dystrophy--reason for optimism? Burton EA; Davies KE Cell; 2002 Jan; 108(1):5-8. PubMed ID: 11792315 [TBL] [Abstract][Full Text] [Related]
36. The dilemma of manifesting carriers in the context of myoblast transplantation. Kunkel LM Adv Exp Med Biol; 1990; 280():285-6. PubMed ID: 2248149 [No Abstract] [Full Text] [Related]
37. [Therapeutic trials with galantamine in Duchenne-Griesinger-type progressive muscular dystrophy]. SERAFINI L; BONVINI E Rass Clin Sci; 1961 Jan; 37():20-4. PubMed ID: 13750156 [No Abstract] [Full Text] [Related]
38. [Reflexions apropos of recent progresses in molecular genetics of myopathies]. Kaplan JC Arch Pediatr; 1995 Aug; 2(8):715-8. PubMed ID: 7550833 [No Abstract] [Full Text] [Related]
39. Genetics and biochemistry of muscular dystrophy. N Engl J Med; 1965 Nov; 273(20):1107-8. PubMed ID: 5834823 [No Abstract] [Full Text] [Related]